The Cancer

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Chris Draft mentioned sufferers with lung most cancers and their caregivers can regain management after analysis by displaying up, staying knowledgeable and leaning into advocacy,...

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Vital Information

Facts

Latest Articles

Pelabresib and Rituxan Combo Improves Outcomes in Myelofibrosis

Pelabresib plus Rituxan improved spleen measurement and signs in untreated myelofibrosis, assembly the primary objective of the MANIFEST-2 trial.Pelabresib (CPI-0610) remedy together with...

A Journey of Assist and Hope

From left: Christine Simonelli, B.S.N., RN, CCRC, OCN, and Tina M. Mason, PH.D., APRN, AOCN, AOCNS, FCNSChristine Simonelli, B.S.N., RN, CCRC, OCN, is...

Personalizing Prostate Most cancers Care With Genetic Testing, PARP Inhibitors

Dr. Kristen Scarpato explains the position of genetic testing in prostate most cancers care: © inventory.adobe.com.Precision drugs has revolutionized the therapy of prostate...

Tracing a 5-Era Most cancers Legacy Via Genetic Discovery

Sue McCarthy acquired diagnoses of breast most cancers in 2001 and lung most cancers in 2018. Compensate for all of Sue's blogs right here!My...

Patritumab Deruxtecan BLA Withdrawn in Non-Small Cell Lung Most cancers

The FDA utility for patritumab deruxtecan in handled EGFR-mutant lung most cancers was withdrawn after confirmatory trial knowledge missed survival objectives.The biologics license...

Hot Topics